Ovarian cancer: understanding symptoms, risk factors, and detection

Changes that persist for weeks, feel out of character, or worsen over time deserve attention—especially when several symptoms appear together. Ovarian cancer is not always found at an early stage because there is no single routine test that reliably detects it in people without symptoms. Understanding how risk, symptoms, and diagnostic steps fit together can make clinical conversations clearer.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

Ovarian cancer symptoms, risk factors, and detection

Ovarian cancer often causes vague, non-specific symptoms, which is why symptom pattern and duration matter. Commonly reported concerns include persistent bloating or increased abdominal size, pelvic or abdominal pain, feeling full quickly or loss of appetite, and urinary urgency or frequency. Some people also notice fatigue, changes in bowel habits (constipation or diarrhea), back pain, or unexplained weight change. These issues are frequently caused by non-cancer conditions, but a key red flag is persistence—symptoms that occur more than a few times per week for several weeks, or that represent a clear change from a person’s usual baseline.

Who’s at Higher Risk: Understanding Risk Factors

Risk is influenced by genetics, age, and reproductive history, but many people diagnosed have no known high-risk factor. Risk generally increases with age, especially after menopause. A strong family history of ovarian, breast, pancreatic, or certain colorectal cancers can suggest an inherited predisposition. Pathogenic variants in genes such as BRCA1/BRCA2 and those associated with Lynch syndrome are linked to higher risk, and this is one reason genetic counseling may be recommended in some situations.

Other factors sometimes associated with risk include endometriosis and long-term exposure to ovulation cycles across a lifetime, while factors that reduce the number of ovulations—such as pregnancy, breastfeeding, and use of combined oral contraceptives—have been associated with lower risk in many studies. Because individual risk profiles vary, clinicians typically consider the full picture rather than a single factor.

Recognizing Early Symptoms: When to See a Clinician

It can be hard to know when to seek evaluation because early symptoms can look like indigestion, stress, or urinary tract irritation. A practical approach is to track what is new, frequent, and persistent. Consider checking in with a clinician if you notice bloating or abdominal distension that does not resolve, pelvic or abdominal pain that recurs, early satiety that affects normal eating, or urinary changes without clear infection—particularly if these symptoms occur repeatedly over several weeks.

Seek more urgent medical attention for severe abdominal pain, signs of bowel obstruction (such as persistent vomiting and inability to pass stool or gas), fainting, or rapid abdominal swelling. When you do see a clinician, bringing a short symptom timeline—when it started, how often it happens, what makes it better or worse, and any associated weight or appetite changes—can improve the quality of the assessment.

Screening and Diagnostic Tests: What They Can and Cannot Do

A frequent point of confusion is the difference between screening and diagnostic testing. Screening tests are used in people without symptoms to detect disease early. At present, no screening method has been proven reliable enough for routine ovarian cancer screening in the general population. Blood tests such as CA-125 can be elevated for many non-cancer reasons (including benign ovarian cysts, endometriosis, and inflammation), and some ovarian cancers do not raise CA-125—especially early on.

Transvaginal ultrasound can help evaluate ovaries and identify masses, but it cannot definitively determine whether a finding is cancer. If an adnexal mass is seen, clinicians assess features such as size, complexity, solid components, and blood flow patterns, often combining imaging findings with symptoms, age, and selected blood markers. Definitive diagnosis typically requires tissue evaluation, which may occur during surgery, and staging is based on how far disease has spread.

Evaluation, Referral, and Follow-Up Care

Evaluation usually starts with a medical history and physical exam, often including a pelvic exam. Depending on symptoms and initial findings, a clinician may order pelvic imaging (commonly transvaginal ultrasound), selected blood tests (which may include CA-125), and sometimes CT or MRI to clarify anatomy or assess possible spread. The goal is to differentiate common benign causes from conditions requiring specialist care.

Referral is important when the level of suspicion is higher or when imaging suggests a complex ovarian mass. Many guidelines emphasize that care involving a gynecologic oncologist can be beneficial for suspected ovarian malignancy, because these specialists are trained in cancer staging and tumor-reductive surgery. Follow-up depends on results: benign-appearing cysts may be monitored with repeat imaging, while concerning findings may lead to advanced imaging, surgical planning, and discussion of pathology-based treatment options such as surgery, chemotherapy, targeted therapy, or participation in appropriate clinical trials. Follow-up also commonly includes symptom monitoring and, when relevant, genetic counseling to inform both treatment planning and family risk assessment.

Ovarian cancer is challenging to detect early because symptoms can be subtle and there is no dependable routine screening test for average-risk people. Focusing on symptom persistence and change from baseline, understanding personal and family risk factors, and knowing what common tests can realistically show helps people navigate evaluation steps more confidently. When concerns arise, a structured clinical assessment and appropriate referral can clarify the cause and guide next steps.